Kornitzer Capital Management Inc Castle Biosciences Inc Transaction History

Kornitzer Capital Management Inc

$5.27 Billion
Q1 2024

A detailed history of Kornitzer Capital Management Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 542,874 shares of CSTL stock, worth $11.5 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

542,874

Previous 542,874 -0.0%

Holding current value

$11.5 Million

Previous $11.7 Million 2.64%

% of portfolio

0.23%

Previous 0.23%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$12.19 - $22.43 $1.28 Million - $2.36 Million	-105,350 Reduced 16.25%	542,874 $11.7 Million
Q1 2023 May 09, 2023	SELL	$19.47 - $28.49 $1.32 Million - $1.94 Million	-68,020 Reduced 9.5%	648,224 $14.7 Million
Q4 2022 Feb 02, 2023	BUY	$18.08 - $30.0 $1.66 Million - $2.76 Million	92,048 Added 14.75%	716,244 $16.9 Million
Q3 2022 Nov 03, 2022	SELL	$22.51 - $34.32 $389,783 - $594,285	-17,316 Reduced 2.7%	624,196 $16.3 Million
Q2 2022 Aug 03, 2022	BUY	$16.0 - $45.99 $3.15 Million - $9.07 Million	197,170 Added 44.37%	641,512 $14.1 Million

Q4 2021 Feb 01, 2022	BUY	$39.06 - $67.58 $3.93 Million - $6.79 Million	100,525 Added 29.24%	444,342 $19 Million
Q2 2021 Jul 30, 2021	BUY	$50.07 - $76.78 $3.9 Million - $5.98 Million	77,940 Added 29.31%	343,817 $25.2 Million
Q1 2021 Apr 30, 2021	BUY	$58.92 - $97.33 $5.43 Million - $8.97 Million	92,115 Added 53.01%	265,877 $18.2 Million
Q4 2020 Jan 29, 2021	BUY	$43.6 - $73.05 $583,673 - $977,920	13,387 Added 8.35%	173,762 $11.7 Million
Q3 2020 Oct 30, 2020	BUY	$38.47 - $52.03 $957,710 - $1.3 Million	24,895 Added 18.38%	160,375 $8.25 Million
Q2 2020 Aug 03, 2020	BUY	$27.28 - $43.01 $3.7 Million - $5.83 Million	135,480 New	135,480 $5.11 Million

Others Institutions Holding CSTL

# of Institutions

162

Shares Held

25.3M

Call Options Held

82.2K

Put Options Held

150K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.

Account

Kornitzer Capital Management Inc Castle Biosciences Inc Transaction History